Heart failure affects millions of people around the globe, and is expected to rise as populations age and diagnosis improves. To assess the impact of heart failure in the round, the CardioRenal and Metabolic disease (CaReMe) heart failure study was designed to estimate the prevalence, key unfavorable outcomes, and costs of the condition for 11 countries. The researchers summarised and pooled the individual healthcare systems data for more than 600,000 people with diagnosed heart failure in the participating countries between 2018 and 2020. The prevalence of heart failure among adults was 2% when applying the broad definition, and 1% when applying the strict definition, across all 11 countries and more than 32 million people. Risks of annual hospital admission were highest for those with heart failure and chronic kidney disease (19%) and the annual death rate was 13%. The costs of hospital care were highest for those with both heart and kidney disease, and higher than those stemming from coronary artery disease and stroke. These findings indicate the need for urgent action.
Prevalence of Heart Failure in 11 Countries
Up to 2% of adults in Europe, North America, and Israel likely have heart failure, and are at high risk of death and additional serious complications, suggest current estimates based on digital health records for 11 countries. The costs of hospital care were highest for those with both heart and kidney disease, and higher than those stemming from coronary artery disease and stroke.
Latest from Blog
Doctors in the Upstate are conducting clinical trials on a cancer immunology vaccine that has the
A tiny fragment from the most dangerous asteroid in the solar system has arrived in the
Scientists have discovered a planet that is way too big for its tiny star. Its existence
No. 4 Florida State is aiming to win their 16th conference championship, taking on No. 14
Prince Harry and Meghan have been left off the guest list for the high society wedding
